H. Christopher Boehning and Daniel J. Toal of Paul, Weiss, Rifkind, Wharton & Garrison discuss 'Freedman v. Weatherford International', which involved a party seeking discovery of materials meant to ...

French preclinical CRO NovAliX has found a new partner across the pond. Massachusetts-based manufacturer Bruker Corporation has announced a minority investment in the CRO. “This partnership with ...

There’s no doubt that large language models and generative AI tools have taken the world by storm. Their ability to create, automate, and analyse is continuing to transform the way we work and ...

insights from industryDr. Xiabing HanPrincipal Scientist for Antibody DiscoveryRapid Novor In this interview, News-Medical had the opportunity to speak with Dr. Xiaobing Han, Principal Scientist for ...

Developing new pharmaceuticals is a complex and costly process that requires innovation and efficiency. High-throughput immunoassays (HTIs) are an emerging technology poised to accelerate the drug ...

In drug discovery, virtual screening is a fast and cost-effective way of narrowing down vast chemical libraries to identify the most promising hits, reducing synthesis and testing requirements while ...

Antimicrobial resistance is one of the top ten threats to public health worldwide. It occurs when bacteria, viruses, fungi, and parasites do not respond to antimicrobial drugs anymore. Drug-resistant ...

Scientists at Scripps Research have developed a novel method that uses artificial intelligence (AI) and advanced imaging techniques to more accurately and efficiently identify therapeutic antibodies ...